Replies to post #27806 on Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

In the statement..It is ambiguous.. RXPC was a voided Delaware Corporation and AMDL Diagnostics was a Delaware corporation..You can see by the wording that AMDL Diagnostics is what they were referring to, that make it appear that they were referring to RXPC..Too funny lol

"Radient Pharmaceuticals Corporation (including its subsidiary AMDL Diagnostics Inc.) a Delaware incorporated United States company (“RXPC”).

http://www.sec.gov/Archives/edgar/data/838879/000121390013003193/f8k061113a1ex10i_radient.htm

c)

Notice of manufacture or modification of product by UNI or the sub-contracting of manufacture (including modification by sub-contractor) of licensed product outside of the United States must be sent to RXPC.

[dcspka]

Question: If Radient could not legally enter into an agreement after March 1, 2013- then why did they attempt to do so with Uni-Pharma. It seems like a lot of trouble for a dead-on-arrival agreement? It's also a good way to have a shareholder revolt complete with lawsuits to follow.

I for one think the whole agreement is null and void simply due to non-compliance clauses. Neither party lived up to sales and/or payment agreements- at least what we know anyway.